[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Page 13954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06845]



[[Page 13954]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The applicant listed below has submitted an application for 
registration to the Drug Enforcement Administration (DEA) to become an 
importer of a schedule I controlled substance.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as an importer of a basic class of controlled substance. 
Information on the previously published notice is listed in the table 
below. No comments or objections were submitted and no requests for a 
hearing were submitted for this notice.

------------------------------------------------------------------------
             Company                   FR docket          Published
------------------------------------------------------------------------
Almac Clinical Services Incorp     84 FR 3253......  February 11, 2019.
 (ACSI).
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed applicant to 
import the applicable basic class of schedule I controlled substance is 
consistent with the public interest and with United States obligations 
under international treaties, conventions, or protocols in effect on 
May 1, 1971. The DEA investigated the company's maintenance of 
effective controls against diversion by inspecting and testing the 
company's physical security system, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer of a schedule I controlled substance to the above listed 
company.

    Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-06845 Filed 4-5-19; 8:45 am]
BILLING CODE 4410-09-P